Amount: between $100,000 and $150,000 of up to 33% of eligible costs
INOVAIT provides Canada’s image-guided therapy (IGT) industry and academic institutions with targeted non-dilutive funding for commercialization-focused R&D projects involving the integration of artificial intelligence (AI) into IGT technologies. The funding will reimburse up to one-third of eligible supported project costs for projects selected through our application process.
Eligibility requirements
This competition is open to Canadian corporations, academic institutions, and not-for-profit organizations. Each project must involve two to four Canadian collaborators and must actively involve at least one Canadian small and medium enterprise (SME). At least one collaborator must be based in a province or territory outside of Ontario.
Eligibility activities
The Pilot Fund will support collaborative research and development (R&D) projects with an aim towards commercialization. All projects must involve the integration of artificial intelligence or advanced data capabilities into an image-guided therapy technology. Funding will support industrial research, including activities related to the discovery of new knowledge that aim to support the development of new technology-driven products or services and large-scale technology demonstration, including the advancement and development of new technologies into product-specific applications.
Amount
Projects may request between $100,000 and $150,000. INOVAIT contributes up to one-third (33.33%) of total eligible supported costs in the form of reimbursement funding.
Timeline
A call for applications for Pilot Fund is accepting applications between February 5, 2025 and April 2, 2025.
